Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesNeurology/NeurosurgerySummaCare Neuropsych Testing Prior Auth | OpenPaye…
    Ask Trek AI about this page
    CurrentSummaCarePolicy N/A

    Neuropsychological Testing Policy

    Customize your policy alerts

    Sign up for all summacare policy alerts

    Know when summacare releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs medical necessity and coverage criteria for neuropsychological testing for SummaCare commercial and Medicare members, including authorized indications, testing standards, exclusions, administration requirements, and applicable CPT codes.

    Policy Summary
    PayerSummaCare
    PolicyNeuropsychological Testing Policy
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateOct 8, 2026
    Last ReviewOct 8, 2026
    Next Review DateN/A
    Key ActionCommercial neuropsychological testing requires authorization and documentation of the qualifying clinical suspicion, necessary time or units, and appropriate validated, nonredundant instruments.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    13Medicare medically necessary indication categories
    9CPT code groups or codes listed
    4Commercial authorization requirements
    6Experimental or investigational use categories

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    2Member populations addressed

    Medical Necessity and Coverage Criteria

    Commercial Medical Necessity Criteria

    For commercial members, neuropsychological testing is medically necessary when the information obtained will support a diagnosis, prognosis, or treatment plan and all of the following criteria are met.

    Commercial medical necessity

    • Qualifying clinical suspicion

      • Qualifying conditions: Autism spectrum disorder; brain tumor; cerebral anoxic or hypoxic episode; central nervous system infection with neurocognitive problems; dementia; demyelinating disease such as multiple sclerosis; epilepsy or seizure disorders; exposure to agents associated with cerebral dysfunction; extrapyramidal disease such as Parkinson's or Huntington's disease; post-concussion syndrome; stroke or cerebral vascular injury; traumatic brain injury; or concussion and mild cognitive impairment associated with a change in mental status, suspected underlying central nervous system condition, and failure of standard treatment.
    • Requested testing time: The number of hours or units requested does not exceed the reasonable time necessary to address the clinical questions with the identified measures.
    • Nonredundant techniques: Testing techniques are not redundant measurements of the same cognitive, behavioral, or emotional domain.
    • Validated and current instruments: Testing techniques are validated for the member's age and population and are the most updated version of the instrument.
    • Psychometric and normative support: Selected tests have empirically substantiated reliability, validity, standardized administration, and clinically relevant normative data to assess the diagnostic question or treatment-planning goals.

    Medicare Medically Necessary Indications

    For Medicare members, neuropsychological testing is medically necessary when any of the following indications is clinically applicable.

    Medicare medically necessary indications

    • Diagnostic clarification: Mild or questionable deficits on standard mental-status testing or clinical interview require testing to establish abnormalities or distinguish them from normal aging or expected disease progression.
    • Diagnosis with clinical data: Neuropsychological data can be combined with clinical, laboratory, and neuroimaging data to establish a diagnosis in neurologic or systemic conditions affecting central nervous system function.
    • Quantification and prognosis: Testing is needed to quantify cognitive or behavioral deficits related to central nervous system impairment, determine prognosis, or inform treatment planning and disease-progression assessment.

    Neuropsychological testing is experimental and investigational when used for educational or vocational assessment or training, improving academic performance, or baseline assessment of function. It is also not covered for monitoring chronic conditions without a significant new change in behavior, mental state, or cognition; diagnosing or managing chronic fatigue syndrome; evaluating migraines; or computerized testing that does not require interpretation and report preparation by a physician, psychologist, or licensed mental health professional.

    Neuropsychological testing is not covered when the member is actively abusing substances, experiencing acute withdrawal symptoms, or has recently entered recovery, because the test results may be invalid.

    CPT Coding

    Covered CPT CodesCPTCovered
    96116Neurobehavioral status exam (clinical assessment of thinking, reasoning and judgment, eg, acquired knowledge, attention, language, memory, planning and problem solving, and visual spatial abilities), per hour of the psychologist's or physician's time, both face-to-face time with the patient and time interpreting test results and preparing the report
    96121Neurobehavioral status examination (clinical assessment of thinking, reasoning and judgment, [eg, acquired knowledge, attention, language, memory, planning and problem solving, and visual spatial abilities]), by physician or other qualified health care professional, both face-to-face time with the patient and time interpreting test results and preparing the report; each additional hour (List separately in addition to code for primary procedure)
    96125Standardized cognitive performance testing (eg, Ross Information Processing Assessment) per hour of a qualified health care professional's time, both face-to-face time administering tests to the patient and time interpreting these test results and preparing the report
    96130-96131Psychological testing evaluation services by physician or other qualified health care professional, including integration of patient data, interpretation of standardized test results and clinical data, clinical decision making, treatment planning and report, and interactive feedback to the patient, family member(s) or caregiver(s), when performed
    96132-96133Neuropsychological testing evaluation services by physician or other qualified health care professional, including integration of patient data, interpretation of standardized test results and clinical data, clinical decision making, treatment planning and report, and interactive feedback to the patient, family member(s) or caregiver(s), when performed
    96136-96137Psychological or neuropsychological test administration and scoring by physician or other qualified health care professional, two or more tests, any method
    96138-96139Psychological or neuropsychological test administration and scoring by technician, two or more tests, any method
    96146Psychological or neuropsychological test administration, with single automated, standardized instrument via electronic platform, with automated result only
    Neutral CPT CodesCPT
    96116Neurobehavioral status exam (clinical assessment of thinking, reasoning and judgment, eg, acquired knowledge, attention, language, memory, planning and problem solving, and visual spatial abilities), per hour of the psychologist's or physician's time, both face-to-face time with the patient and time interpreting test results and preparing the report
    96121Neurobehavioral status examination (clinical assessment of thinking, reasoning and judgment, [eg, acquired knowledge, attention, language, memory, planning and problem solving, and visual spatial abilities]), by physician or other qualified health care professional, both face-to-face time with the patient and time interpreting test results and preparing the report; each additional hour (List separately in addition to code for primary procedure)
    96125Standardized cognitive performance testing (eg, Ross Information Processing Assessment) per hour of a qualified health care professional's time, both face-to-face time administering tests to the patient and time interpreting these test results and preparing the report
    96130-96131Psychological testing evaluation services by physician or other qualified health care professional, including integration of patient data, interpretation of standardized test results and clinical data, clinical decision making, treatment planning and report, and interactive feedback to the patient, family member(s) or caregiver(s), when performed
    96132-96133Neuropsychological testing evaluation services by physician or other qualified health care professional, including integration of patient data, interpretation of standardized test results and clinical data, clinical decision making, treatment planning and report, and interactive feedback to the patient, family member(s) or caregiver(s), when performed
    96136-96137Psychological or neuropsychological test administration and scoring by physician or other qualified health care professional, two or more tests, any method
    96138-96139Psychological or neuropsychological test administration and scoring by technician, two or more tests, any method
    96146Psychological or neuropsychological test administration, with single automated, standardized instrument via electronic platform, with automated result only

    Authorization, Documentation, and Administration

    Prior Authorization

    Commercial Authorization and Medical Necessity

    Prior authorization and commercial medical-necessity requirements apply. Commercial neuropsychological testing is medically necessary when the information will support a diagnosis, prognosis, or treatment plan and all applicable criteria are met.

    • There is reasonable suspicion of a qualifying neurologic or neurocognitive condition, including autism spectrum disorder, brain tumor, cerebral anoxic or hypoxic episode, CNS infection with neurocognitive problems, dementia, demyelinating disease, epilepsy or seizure disorders, cerebral-dysfunction exposure, extrapyramidal disease, post-concussion syndrome, stroke or cerebral vascular injury, traumatic brain injury, or qualifying concussion/mild cognitive impairment.
    • Requested testing hours or units do not exceed the reasonable time needed to address the clinical questions with the identified measures.
    • Techniques are nonredundant, validated for the member's age and population, current versions, and supported by empirically established reliability, validity, standardized administration, and clinically relevant normative data.
    Note

    Medicare Carrier Coverage Review

    Clinical Background

    Neuropsychological testing uses standardized assessments to identify brain damage, injury, or dysfunction and related functional deficits. Results should not be interpreted from a single test in isolation; they should be considered together with the medical and neurologic examination. Testing is generally associated with neurologic diagnoses and should be administered by a licensed psychologist or psychiatrist with appropriate expertise.

    Key Definition

    Neuropsychological testing
    DefinitionA series of standardized assessments focused on identifying the presence of brain damage, injury, or dysfunction and related functional deficits.
    Assessment purposeMeasures cognitive and related functional deficits to support clinical evaluation.
    InterpretationResults must not be based on a single test result and should be assessed in the context of the medical and neurological examination.
    Clinical contextTesting is customarily associated with neurological diagnoses rather than behavioral health diagnoses.
    Qualified providerTesting should be administered by a licensed psychologist or psychiatrist with expertise in the appropriate area.
    Policy Summary
    PayerSummaCare
    PolicyNeuropsychological Testing Policy
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateOct 8, 2026
    Last ReviewOct 8, 2026
    Next Review DateN/A
    Key ActionCommercial neuropsychological testing requires authorization and documentation of the qualifying clinical suspicion, necessary time or units, and appropriate validated, nonredundant instruments.
    SourceLink
    On This Page
    Medical Necessity and Coverage CriteriaCPT CodingAuthorization, Documentation, and AdministrationClinical BackgroundKey Definition
    Presurgical or treatment-related assessment:
    Testing is needed to determine whether a patient can safely proceed with a medical or surgical procedure that may affect brain function or significantly alter functional status, including deep brain stimulation, brain tumor or arteriovenous malformation resection, epilepsy surgery, or stem cell transplant.
  1. Therapeutic adverse effects: Testing is needed to assess potential cognitive effects of radiation, chemotherapy, antiepileptic medications, or other therapeutic substances, particularly when used for treatment planning.
  2. Monitoring CNS disease: Testing is needed to monitor progression, recovery, or response to changing treatment in patients with central nervous system disorders to establish the most effective plan of care.
  3. Subjective cognitive complaints: Objective measurement of memory, attention, or other cognitive complaints is needed to guide treatment and differentiate psychogenic from neurogenic syndromes, such as dementia versus depression.
  4. Functional abilities and impairments: Testing is needed to establish a treatment plan by determining functional abilities or impairments in individuals with known or suspected central nervous system disorders.
  5. Capacity and participation: Testing is needed to determine whether a patient can comprehend and participate effectively in complex treatment regimens or to determine capacity for health care decisions, work, independent living, or management of financial affairs.
  6. Cognitive rehabilitation: Testing is needed to design, administer, or monitor cognitive rehabilitation procedures such as compensatory memory training for brain-injured patients.
  7. Systemic disease sequelae: Testing is needed to identify and assess neurocognitive sequelae of systemic disease, such as hepatic encephalopathy or anoxic/hypoxic injury associated with cardiac procedures, for treatment planning.
  8. Neuropsychiatric rehabilitation and management: Testing is needed to formulate rehabilitation or management strategies for individuals with neuropsychiatric disorders.
  9. Pediatric and adolescent developmental concerns: Testing is needed to diagnose cognitive or functional deficits in children or adolescents who cannot develop expected knowledge, skills, or abilities needed to adapt to new or changing cognitive, social, emotional, or physical demands.
  10. Medicare coverage is subject to carrier-specific review because no CMS National Coverage Determination was identified. Apply the applicable Medicare carrier policy and review pathway for psychological and neuropsychological testing.

    • Carrier reference identified: LCD L34646, Psychological and Neuropsychological Testing, WPS Insurance Corporation.
    • Do not assume that the absence of a CMS NCD establishes coverage; the Medicare carrier makes the coverage determination.
    Documentation Required

    Document Clinical Rationale and Test Justification

    Document the clinical question being answered and how the expected results will provide meaningful diagnostic, prognostic, or treatment-planning value. Testing should be interpreted in the context of the medical and neurological examination rather than relying on a single test result.

    • Explain the suspected condition or functional concern prompting testing.
    • Link the selected measures and requested testing time to the expected clinical decision or treatment plan.
    Documentation Required

    Select Tests Within the Clinical Context

    Use an integrated, patient-specific process to select tests. Combine medical records, clinical interview, behavioral observations, education, premorbid functioning, sensory and physical abilities, fatigue, age, ethnicity, and the goals of testing.

    • Select measures appropriate to the diagnostic or treatment-effect question.
    • Avoid redundant measurement of the same cognitive, behavioral, or emotional domain.
    • Use instruments validated for the member's age and population, the most current version, and tests with reliable, valid, standardized, and clinically relevant normative support.
    Note

    Qualified Administration and Supervision

    Tests must be administered either directly by a Medicare provider with an appropriate state license or by a trained technician under the provider's direct supervision. Ensure the administrator and supervision arrangement meet applicable licensure and payer requirements.

    • The interpreting provider should have appropriate expertise in neuropsychological testing.
    • A technician may perform testing only when directly supervised by the provider.

    Unsupported block type: denial_risk

    Denial Risk

    Experimental or Investigational Uses

    Neuropsychological testing is experimental and investigational for specified educational, vocational, academic, baseline, chronic-condition monitoring, and other noncovered purposes. Computerized testing is also experimental and investigational when the indication does not require physician, psychologist, or licensed mental-health-professional interpretation and report preparation.

    • Educational or vocational assessment or training, including improving academic performance.
    • Baseline assessment of function.
    • Monitoring chronic conditions without a significant new change in behavior, mental state, or cognition.
    • Diagnosis and management of chronic fatigue syndrome or evaluation of migraines.
    • Computerized testing that does not require qualified professional interpretation and preparation of a report.
    Denial Risk

    Commercial Medical-Necessity Denial Risks

    Commercial coverage may be denied when the request does not establish a reasonable suspicion of a qualifying condition or when the testing lacks required clinical utility. Requests may also fail medical-necessity review when they exceed reasonable time, use redundant or unsuitable measures, or lack validated and clinically relevant instruments.

    • Show how the testing will support diagnosis, prognosis, or a treatment plan.
    • Do not request more hours or units than are reasonably necessary for the identified clinical questions.
    • Do not rely on a single test result or measures that are redundant, outdated, unvalidated for the member, or unsupported by appropriate normative data.